Emcure Pharmaceuticals initial public offerings (IPO), which opened for subscription on Wednesday, was fully subscribed by the later half of the first day of bidding, driven by strong demand from non-institutional investors. The issue has been subscribed 1.22 times in the retail category and 1.92 times in the NII portion, on June 3. However, there …
Emcure Pharmaceuticals IPO: The mainboard initial public offering (IPO) of leading pharma major Emcure Pharmaceuticals Ltd will open for subscription on Wednesday, July 3, 2024. The company develops and manufactures various pharmaceutical products across several major therapeutic areas. Emcure Pharma’s product portfolio consists of injectables, biotherapeutics, and orals. The research and development (R&D)-driven firm has …
The Pune-based Emcure Pharma is all set to launch its initial public offerings (IPO) next week. The IPO will open for subscription on July 3 and will close on July 5. The shares of Emcure Pharma IPO is trading at a premium of ₹255 in the grey market premium (GMP) on Saturday, June 29, just …